Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2209 |  INBX Inhibrx Biosciences, Inc. - Common Stock | 92.76 USD | -0.64% | -6.59% | -20.97% | +15.12% | 1.37 B USD | ||
| 2211 |  AAPG Ascentage Pharma Group International - American Depository Shar | 14.55 USD | -4.09% | -4.59% | -15.55% | -41.80% | 1.36 B USD | ||
| 2218 |  ANAB AnaptysBio, Inc. - Common Stock | 46.21 USD | +1.23% | -5.64% | -16.87% | +31.28% | 1.34 B USD | ||
| 2244 |  GHRS GH Research PLC - Ordinary Shares | 20.45 USD | -2.90% | -11.28% | -26.36% | +44.42% | 1.27 B USD | ||
| 2253 |  ORIC Oric Pharmaceuticals, Inc. - Common Stock | 12.03 USD | +0.17% | -5.42% | -3.76% | -10.95% | 1.25 B USD | ||
| 2262 |  DRTS Alpha Tau Medical Ltd. - Ordinary Shares | 14.00 USD | -1.75% | -4.96% | +1.45% | +262.69% | 1.23 B USD | ||
| 2265 |  REPL Replimune Group, Inc. - Common Stock | 13.04 USD | -1.21% | -4.75% | -9.88% | +179.83% | 1.23 B USD | ||
| 2277 |  TYRA Tyra Biosciences, Inc. - Common Stock | 19.97 USD | -2.06% | -6.02% | +5.44% | +39.26% | 1.19 B USD | ||
| 2302 |  BCAX Bicara Therapeutics Inc. - Common Stock | 17.26 USD | +5.12% | -5.37% | -26.14% | +19.53% | 1.14 B USD | ||
| 2310 |  VOR Vor Biopharma Inc. - Common Stock | 19.13 USD | +1.86% | +5.75% | -21.82% | +46.03% | 1.13 B USD | ||
| 2311 |  JANX Janux Therapeutics, Inc. - Common Stock | 18.50 USD | +3.24% | +7.25% | -3.50% | -29.31% | 1.13 B USD | ||
| 2321 |  LBRX LB Pharmaceuticals Inc - Common Stock | 34.61 USD | +1.32% | -8.24% | -29.47% | +130.58% | 1.12 B USD | ||
| 2330 |  NBTX Nanobiotix S.A. - ADSs | 22.90 USD | -6.99% | -16.39% | -38.09% | -14.07% | 1.11 B USD | ||
| 2332 |  MNKD MannKind Corporation - Common Stock | 3.42 USD | -0.87% | -14.71% | -17.79% | -35.47% | 1.10 B USD | ||
| 2384 |  MGTX MeiraGTx Holdings plc - Ordinary Shares | 10.50 USD | -2.96% | -2.33% | -21.64% | +20.00% | 1.01 B USD | ||
| 2398 |  CGEM Cullinan Therapeutics, Inc. - Common Stock | 15.46 USD | -1.09% | +4.74% | -26.35% | +117.75% | 994.92 M USD | ||
| 2401 |  SVRA Savara, Inc. - Common Stock | 4.83 USD | -1.02% | -5.29% | -9.55% | +40.82% | 992.37 M USD | ||
| 2404 |  IMTX Immatics N.V. - Ordinary Shares | 7.37 USD | -1.07% | -13.90% | -21.43% | -28.79% | 988.11 M USD | ||
| 2429 |  ANRO Alto Neuroscience, Inc. Common Stock | 24.02 USD | +2.08% | -7.97% | -28.30% | +295.07% | 942.60 M USD | ||
| 2434 |  KURA Kura Oncology, Inc. - Common Stock | 10.52 USD | -1.41% | -2.68% | -12.33% | +2.73% | 935.87 M USD |
Nouvelles Biotechnology Stocks
Le médicament de Pharvaris contre l’angiœdème héréditaire soulage plus vite
Raymond James initie une couverture de Kymera Therapeutics avec une note de surperformance
Raymond James initie la couverture de Nektar avec une note Performance Marché
L’action Palisade Bio initiée à Surperformance par Raymond James
Raymond James réitère sa note sur l’action Liquidia malgré les dépôts juridiques
Tenax Therapeutics suspend temporairement le recrutement dans l’essai LEVEL-2 de TNX-103 afin de modifier les critères ; demande une réunion avec la FDA
Ginkgo Bioworks soutient le programme NSF X-Labs avec son laboratoire
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |